Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Dec 1;15(12):e250755.
doi: 10.1136/bcr-2022-250755.

Bullous Sweet syndrome as a presentation of chronic myelogenous leukaemia

Affiliations
Case Reports

Bullous Sweet syndrome as a presentation of chronic myelogenous leukaemia

Syeda Wajiha Abbas et al. BMJ Case Rep. .

Abstract

A woman in her 40s presented with a 3-month-long history of fever and tender erythematous bullous skin lesions not responsive to antibiotics. There had been no previous gastrointestinal, respiratory or urinary infection, nor did she have any history of autoimmune disease, drug reaction or vasculitis.Histological evaluation of skin biopsy showed diffuse dense neutrophilic infiltrates located in dermis diagnostic of Sweet syndrome. Haematological investigations showed leucocytosis with circulating immature cells, which on further investigations with bone marrow biopsy, were evident of chronic myelogenous leukaemia in the accelerated phase. Sweet syndrome was the presenting characteristic of chronic myelogenous leukaemia in this case, which is a rare association. Investigating unusual skin lesions can aid in the suspicion of underlying cancer, allowing for prompt action.

Keywords: Chronic Myeloid Leukemia; Dermatology; Haematology (drugs and medicines); Malignant and Benign haematology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
(A–D) Multiple tender erythematous bullous skin lesions on arms, legs and hands at initial presentation.
Figure 2
Figure 2
(A) Peripheral film showing myeloblasts; (B) peripheral film showing myelocytes and metamyelocytes.
Figure 3
Figure 3
Bone marrow aspirate showing immature myeloid precursors such as blast cells.
Figure 4
Figure 4
(A) Bone marrow trephine showing granulocytic infiltration; (B) bone marrow trephine showing fibrosis.
Figure 5
Figure 5
(A, B) Histopathology slides of the skin biopsy. (A) Ulcerated epidermis with basket-weave keratosis, along with intraepidermal vesicles with marked spongiosis. (B) The underlying dermis exhibits diffuse neutrophilic infiltrate which is extending throughout the whole thickness of the tissue with nuclear debris.

References

    1. Wick MR, Patterson JW. Cutaneous paraneoplastic syndromes. Semin Diagn Pathol 2019;36:211–28. 10.1053/j.semdp.2019.01.001 - DOI - PubMed
    1. Heath MS, Ortega-Loayza AG. Insights into the pathogenesis of sweet's syndrome. Front Immunol 2019;10:414. 10.3389/fimmu.2019.00414 - DOI - PMC - PubMed
    1. Smolovic BD, Gajic-Veljic MD, Nikolic MM, et al. . Pregnancy-induced sweet's syndrome treated with infliximab. Med Princ Pract 2019;28:196–8. 10.1159/000494974 - DOI - PMC - PubMed
    1. Castagnetti F, Gugliotta G, Baccarani M, et al. . Differences among young adults, adults and elderly chronic myeloid leukemia patients. Ann Oncol 2015;26:185–92. 10.1093/annonc/mdu490 - DOI - PubMed
    1. Cohen PR. Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;2:34. 10.1186/1750-1172-2-34 - DOI - PMC - PubMed

Publication types

MeSH terms